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In this issue, Ohta et al. report the ribosomal polymer-
ization of a-hydroxy acids by means of genetic code
reprogramming. The flexizyme system, a ribozyme-
based tRNA acylation tool, was used to reassign indi-
vidual codons to seven types of a-hydroxy acids.
Next, polyesters were synthesized under controls of
the reprogrammed genetic code using a reconstituted
cell-free translation system. The sequence and length
of the polyester segments were specified by the
mRNA template, indicating that high fidelity ribosome
expression of polyesters was possible. This work rep-
resents an exciting, not previously described example
ofmRNA-directed synthesis of polyesters consisting of
several different a-hydroxy acids (Figure credits: Ohta
et al.).
Gain-of-Function Mutational Activation in AARSs
PAGE 1323
Aminoacyl tRNA synthetases (AARS) are a group of enzymes that catalyze the first step of protein biosynthesis, a formation
of a covalent bond between a specific amino acid and its corresponding transfer RNA (tRNA). In addition, the idea of func-
tional expansion of AARSs in higher eukaryotes has been emerging, suggesting a connection between these enzymes and
numerous signal transduction pathways. The work by Yang and colleagues now investigates the mechanism of activation
of an expanded tyrosine tRNA synthetase function. The results shed new light on why mutations in genes for tRNA synthe-
tases, not disruptive for synthetase activity, are causally linked to human diseases and demonstrate that disease-associ-
ated mutations result in gain-of-function.
Squalene Epoxidase in Biosynthesis of Clavaric Acid
PAGE 1334
Clavaric acid is an antitumor agent of substantial pharmacological in-
terest produced by the basidiomycete (mushroom) Hypholoma subla-
teritium. The production of this promising antitumor agent is currently
limited by the low yield of the natural Hypholoma isolates. Godio
et al. now provide evidence that clavaric acid is derived from an iso-
prenoid pathway; more precisely, from squalene. The authors identify
and characterize a gene encoding squalene epoxidase. Microbial over-
expression of this gene leads to clavaric acid overproducer strain and
represents a first step in eliminating limitations of calvaric acid avail-
ability. (Figure credits: Godio et al.)
Brain 2-Arachidonoylglycerol Hydrolase
Profiling
PAGE 1347
The endocannabinoid signalingmolecule 2-arachidonoylglycerol (2-AG)
acts at cannabinoid receptors to regulate a diverse array of phys-
iological processes. 2-AG levels in the central nervous system are
tightly regulated by enzymatic biosynthesis and degradation, but these
pathways have yet to be completely elucidated. In this study, Blankman et al. adopted a functional proteomics approach to
comprehensively profile 2-AG hydrolases in the mouse brain. Their results designate monoacylglycerol lipase (MAGL) as
a principal 2-AG hydrolase in the mouse brain and identify two previously uncharacterized enzymes, ABHD12 and
ABHD6, that also possess this activity.Chemistry & Biology 14, December 2007 ª2007 Elsevier Ltd All rights reserved ix
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TheN-aryl carbamate URB602 is an inhibitor of monoacylglycerol lipase (MGL), a serine hydrolase involved in the biological
deactivation of the endocannabinoid 2-arachidonoylglycerol (2-AG). Using purified recombinant MGL and intact brain neu-
rons, King and colleagues demonstrate the selective inhibitory effects of URB602 onMGL activity. The authors further show
that this inhibition occurs through a partially reversible, noncompetitive mechanism using an approach that combines
kinetic, dialysis, and structure-activity relationship (SAR) analyses. Thus, URB602 remains a useful tool to investigate
the roles of 2-AG and validate MGL as a pharmacological target.
From Targeting Gravitropism to Understanding ABC Transporters
PAGE 1366
P-glycoproteins (PGPs) are ATP-binding cassette (ABC) transporters
that translocate a myriad of molecules across biological membranes.
In plants, a few PGP proteins together with PIN proteins transport the
plant hormone auxin and participate in the physiological changes re-
quired for the response to gravitropic stimuli. Using a genetic and bio-
chemical approach, Rojas-Pierce et al. identified PGP19 as a target of
the gravitropic inhibitor Gravacin in Arabidopsis thaliana. The authors
analyzed the effect of Gravacin on the transport activity of PGP19
and PGP19-PIN complexes, as well as the physical interaction be-
tween Gravacin and PGP19-containing microsomal membranes. Bet-
ter understanding of the Gravacin/PGP19 systemmight lead to a better
understanding of ABC transporters, in general. (Photo credits: Rojas-
Pierce et al.)
New Way to Build a Double Hot-Dog
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Eukaryotic fatty acid megasynthases utilize a dehydratase to catalyze
one of the ß-carbon processing reactions that follow each chain exten-
sion step. Expression, mutagenesis and structural modeling studies by
Pasta et al. suggest that the dehydratase of the animal megasynthase
has evolved from a freestanding, prokaryotic, homodimeric counter-
part that exhibits a typical double hot-dog fold, with two active-sites located at the subunit interface. However, in this
megasynthase, the double hot-dog is formed by two ‘‘pseudosubunits’’ derived from contiguous regions of the same poly-
peptide, and only one active site is retained. This architecture differs from that of fungal megasynthase dehydratases,
even though the enzymes utilize similar catalytic mechanisms.
Emetine Regulates Bcl-x Splicing
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Emetine, the ipecac alkaloid, has been used for treat-
ment of different human disease for centuries. More re-
cently, it was established that emetine acts as a eukary-
otic protein synthesis inhibitor. Moreover, emetine has
been evaluated as a potential chemotherapeutic agent.
However, molecular details of emetine mechanism of
action are still lacking. Boon-Unge et al. present evi-
dence that emetine regulates alternative splicing of
exon 2 in the Bcl-x gene, leading to a decrease in the
amount of anti-apoptotic Bcl-xL and an increase of
proapoptotic Bcl-xS protein levels. Interestingly, au-
thors show that emetine exerts the effects on Bcl-x
splicing in a phosphorylation-dependent manner, with
protein phosphatase-1 mediating these effects. Spe-
cific control of the alternative splicing of Bcl-x gene is
an emerging target for anti-cancer treatment, and em-
etine is a new piece that starts to complete the puzzle.Chemistry & Biology 14, December 2007 ª2007 Elsevier Ltd All rights reserved xi
